470 related articles for article (PubMed ID: 35934007)
1. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
Ballering AV; van Zon SKR; Olde Hartman TC; Rosmalen JGM;
Lancet; 2022 Aug; 400(10350):452-461. PubMed ID: 35934007
[TBL] [Abstract][Full Text] [Related]
2. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.
Boekel L; Atiqi S; Leeuw M; Hooijberg F; Besten YR; Wartena R; Steenhuis M; Vogelzang E; Webers C; Boonen A; Gerritsen M; Lems WF; Tas SW; van Vollenhoven RF; Voskuyl AE; van der Horst-Bruinsma I; Nurmohamed M; Rispens T; Wolbink G
Lancet Rheumatol; 2023 Jul; 5(7):e375-e385. PubMed ID: 37398978
[TBL] [Abstract][Full Text] [Related]
3. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M
Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336
[TBL] [Abstract][Full Text] [Related]
4. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
Molteni E; Sudre CH; Canas LS; Bhopal SS; Hughes RC; Antonelli M; Murray B; Kläser K; Kerfoot E; Chen L; Deng J; Hu C; Selvachandran S; Read K; Capdevila Pujol J; Hammers A; Spector TD; Ourselin S; Steves CJ; Modat M; Absoud M; Duncan EL
Lancet Child Adolesc Health; 2021 Oct; 5(10):708-718. PubMed ID: 34358472
[TBL] [Abstract][Full Text] [Related]
5. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
[TBL] [Abstract][Full Text] [Related]
6. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands.
van der Maaden T; Mutubuki EN; de Bruijn S; Leung KY; Knoop H; Slootweg J; Tulen AD; Wong A; van Hoek AJ; Franz E; van den Wijngaard CC
J Infect Dis; 2023 Apr; 227(9):1059-1067. PubMed ID: 36477364
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Boekel L; Stalman EW; Wieske L; Hooijberg F; van Dam KPJ; Besten YR; Kummer LYL; Steenhuis M; van Kempen ZLE; Killestein J; Volkers AG; Tas SW; van der Kooi AJ; Raaphorst J; Löwenberg M; Takkenberg RB; D'Haens GRAM; Spuls PI; Bekkenk MW; Musters AH; Post NF; Bosma AL; Hilhorst ML; Vegting Y; Bemelman FJ; Voskuyl AE; Broens B; Parra Sanchez A; van Els CACM; de Wit J; Rutgers A; de Leeuw K; Horváth B; Verschuuren JJGM; Ruiter AM; van Ouwerkerk L; van der Woude D; Allaart CF; Teng YKO; van Paassen P; Busch MH; Jallah PBP; Brusse E; van Doorn PA; Baars AE; Hijnen DJ; Schreurs CRG; van der Pol WL; Goedee HS; Vogelzang EH; Leeuw M; Atiqi S; van Vollenhoven R; Gerritsen M; van der Horst-Bruinsma IE; Lems WF; Nurmohamed MT; Boers M; Keijzer S; Keijser J; van de Sandt C; Boogaard A; Cristianawati O; Ten Brinke A; Verstegen NJM; Zwinderman KAH; van Ham SM; Rispens T; Kuijpers TW; Wolbink G; Eftimov F;
Lancet Rheumatol; 2022 Jun; 4(6):e417-e429. PubMed ID: 35527808
[TBL] [Abstract][Full Text] [Related]
10. Symptom profiles and their risk factors in patients with post-COVID-19 condition: a Dutch longitudinal cohort study.
van Zon SKR; Ballering AV; Brouwer S; Rosmalen JGM;
Eur J Public Health; 2023 Dec; 33(6):1163-1170. PubMed ID: 37608757
[TBL] [Abstract][Full Text] [Related]
11. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study).
Mutubuki EN; van der Maaden T; Leung KY; Wong A; Tulen AD; de Bruijn S; Haverman L; Knoop H; Franz E; van Hoek AJ; van den Wijngaard CC
BMJ Open; 2022 Jul; 12(7):e062439. PubMed ID: 35777877
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
14. Characterizing Symptoms and Identifying Biomarkers of Long COVID in People With and Without HIV: Protocol for a Remotely Conducted Prospective Observational Cohort Study.
Márquez NG; Jamal A; Johnston R; Richter EI; Gorbach PM; Vannorsdall TD; Rubin LH; Jennings C; Landay AL; Peluso MJ; Antar AAR
JMIR Res Protoc; 2023 May; 12():e47079. PubMed ID: 37104709
[TBL] [Abstract][Full Text] [Related]
15. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
C-MORE/PHOSP-COVID Collaborative Group
Lancet Respir Med; 2023 Nov; 11(11):1003-1019. PubMed ID: 37748493
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
18. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
19. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
[TBL] [Abstract][Full Text] [Related]
20. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
